Texas suit against J&J over drug to go to trial
AUSTIN, Texas (AP) — Texas is seeking more than $1 billion in damages in a lawsuit that accuses Johnson & Johnson of overstating the safety of an anti-psychotic drug and influencing its use in the state's Medicaid program.
BNY Mellon, Credit Suisse, UBS, Apple, TD Bank in Court News
Bank of New York Mellon Corp. agreed to change its disclosure statements for so-called standing instruction foreign exchange transactions to partly resolve a lawsuit by U.S. prosecutors.
Texas suit against J&J over drug goes to trial
A clash between Texas and Johnson & Johnson that could end up costing the drug maker $1 billion opened Tuesday with prosecutors accusing the company of plundering the state Medicaid program by overstating the safety of an expensive anti-psychotic drug and improperly influencing officials and doctors to push the medication.
J&J Hid 3 Risperdal Diabetes Studies From FDA, Texas Jury Told
Johnson & Johnson (JNJ) officials hid three studies showing some patients using Risperdal developed diabetes while claiming the antipsychotic drug didn’t cause the disease, a witness testified.
Johnson & Johnson Facing Risperdal Lawsuit
Risperdal is one of a numerous amount of anti-psychotic drugs used to treat depression and other mental health conditions, such as bi-polar disease. A new lawsuit is alleging , and potentially proving, that Johnson & Johnson hid three studies linking the drug to diabetes. As early as 1999, Johnson & Johnson’s Janssen unit had researchers’ findings that about half the patients taking Risperdal in ...
Bullock to discuss mental health issues
Butte-area media representatives are invited to an event Jan. 25 to discuss the impact of a Montana Mental Health Trust grant to the Western Montana Mental Health Center in Butte. The grant has provid
Deutsche Bank, News Corp., Samsung, Terra Firma, Barclays in Court News
Ma Sin-chi, a Deutsche Bank AG (DBK) managing director in Hong Kong , was charged with accepting HK$24.8 million ($3.2 million) in bribes in exchange for advice on the trading of derivative warrants issued by the bank.
Johnson & Johnson has Agreed to Pay $158M in Texas Off-Label Marketing Case
Pharmaceutical giant Johnson & Johnson has agreed to a settlement that will have the New Jersery based drug manufacturer paying out $158 million to the state of Texas. Texas officials claim that J&J defrauded the state’s Medicaid program by promoting the drug Risperdal for uses not approved by the FDA, including the treatment of psychiatric disorders in children. The state also alleges that J&J ...
Briefly Around the State + Nation
The Alexander to open in fall The 209-room hotel being built near Eli Lilly and Co.'s headquarters will be called The Alexander, in honor of Alexander Ralston, the Scottish architect- engineer who helped lay out the design for Indianapolis in 1820.